Clinical Trials Browser

Phase 2 × Breast Neoplasms × pirfenidone × Clear all

NCT05704166 2025-08-08

PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

Phase 2 Recruiting

Breast Neoplasms, Acute Lung Injury